scispace - formally typeset
Y

Yasushi Kiyono

Researcher at University of Fukui

Publications -  112
Citations -  2300

Yasushi Kiyono is an academic researcher from University of Fukui. The author has contributed to research in topics: Cerebral blood flow & Standardized uptake value. The author has an hindex of 25, co-authored 103 publications receiving 1968 citations. Previous affiliations of Yasushi Kiyono include Kyoto University.

Papers
More filters
Journal ArticleDOI

Cytotoxic effects of γδ T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy

TL;DR: Findings show that ZOL significantly stimulated the proliferation of gdγδT cells and that gdβδ T cells required pre‐treatment with ZOL for cytotoxic activity against target cells.
Journal ArticleDOI

The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation

TL;DR: A 3D culture system with inorganic nanoscale scaffolding using nanoimprinting technology (nano-culture plates) allows creating uniform and highly-reproducible 3D cultures, which can be used for high-throughput/high-content screening of anticancer drugs and should accelerate discovery of more effective anticancer therapies.
Journal ArticleDOI

Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism

TL;DR: It is found that tumor cells expressed higher levels of cytosolic acetyl‐CoA synthetase (ACSS2) under hypoxia than normoxia, which indicates that ACSS2 is a bi‐directional enzyme in tumor cells and that AC SS2 might play a buffering role in tumor acetyl-CoA/acetate metabolism.
Journal ArticleDOI

Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome

TL;DR: It is demonstrated that uptake of radiolabeled acetate is a useful predictor of FASN-targeted therapy outcome, which suggests that [1-11C]acetate positron emission tomography (PET) could be a powerful tool to accomplish personalized FASn- targeted therapy by non-invasive visualization of tumor acetate uptake and selection of responsive tumors.